DNA Genetics is a leading cannabis brand with a history spanning over thirteen years. It originated in Amsterdam, capitalizing on the city's pioneering legal cannabis market. This strategic positioning allowed DNA Genetics to emerge as a prominent player, offering premium seeds sourced from California to the sole legal market at the time. Through adept maneuvering and by forming strategic alliances, the company expanded its foothold in the European market and ventured into emerging legal markets worldwide. Moreover, DNA Genetics is resolute in its commitment to providing top-tier cannabis seeds for both medicinal and recreational purposes. The company's last investment, totaling $35.00M, was secured through a Corporate Round investment on 03 December 2018, with KES 7 Capital serving as the investor. DNA Genetics stands out as a strong contender in the cannabis industry, leveraging its founding principles and strategic alliances to continuously evolve and adapt to changing legal landscapes. This positions the company as an attractive prospect for investors seeking opportunities in the burgeoning cannabis sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Corporate Round | $35.00M | 1 |
|
03 Dec 2018 |
No recent news or press coverage available for DNA Genetics.
We care about your data, and we'd love to use cookies make your experience better.